Other top stories

Four Key Turning Points Shape the Brain’s Wiring

December 2, 2025

Otsuka Seeks FDA Approval for New ADHD Drug

December 1, 2025

Can a Superhero Make Us Kinder?

November 26, 2025

Sustained Symptom Improvement Across Domains With Long-Term Xanomeline–Trospium Treatment

November 25, 2025

Impact of Dose and Titration Speed on the Tolerability of Xanomeline–Trospium in Schizophrenia

November 25, 2025

Low Rates of Extrapyramidal Symptoms With Long-Term Xanomeline–Trospium Treatment in Schizophrenia

November 25, 2025

Other stories

Teens Are Turning to AI for Support. A New Report Says It’s Not Safe.

November 25, 2025

Student Loan Overhaul Leaves Nurses Behind

November 24, 2025

Weekly Mind Reader: Diabetes Drug Shows Unexpected Promise

November 21, 2025

Promising Brain-Fog Therapies Fall Flat in Long COVID Trial

November 20, 2025

Concussions Carry a Hidden Long-Term Risk

November 19, 2025

NAD+ Revives Memory In Alzheimer’s Models

November 18, 2025

Consensus Report on XT Use in Practice

Read the full report
Figure: Graphic promoting Consensus Report on Xanomeline-Trospium; colorful net design shown with JCP logo in lower left.

Subscribe to read
more articles

Subscribe